These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38526291)
1. Delayed Response to Glucocorticoids in Daptomycin Lung. Nanah A; Nair AS; Stoller J Am J Ther; 2024 Jul-Aug 01; 31(4):e518-e521. PubMed ID: 38526291 [No Abstract] [Full Text] [Related]
2. Daptomycin in treatment of Methicillin-resistant Staphylococcus aureus diskitis. Parlato C; di Nuzzo G; Luongo M; Esposito S; Moraci A Neurol Sci; 2011 Aug; 32(4):747-8. PubMed ID: 21327398 [No Abstract] [Full Text] [Related]
3. Daptomycin-induced pneumonitis in a patient with chronic obstructive pulmonary disease (COPD). Yamamoto K; Hayakawa K; Ohmagari N Intern Med; 2014; 53(21):2559-60. PubMed ID: 25366026 [No Abstract] [Full Text] [Related]
4. Daptomycin-associated eosinophilic pneumonia in two patients with prosthetic joint infection. Yusuf E; Perrottet N; Orasch C; Borens O; Trampuz A Surg Infect (Larchmt); 2014 Dec; 15(6):834-7. PubMed ID: 25317960 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections. Lai CC; Sheng WH; Wang JT; Liao CH; Ho MW; Chen CJ; Chen DL; Chou MU; Lee CM; Lin YC; Pong MY; Chang SC J Microbiol Immunol Infect; 2012 Feb; 45(1):52-7. PubMed ID: 22153759 [TBL] [Abstract][Full Text] [Related]
7. Neutropenia associated with prolonged daptomycin use. Knoll BM; Spieler PJ; Kubiak DW; Marty FM Clin Infect Dis; 2013 May; 56(9):1353-4. PubMed ID: 23325425 [No Abstract] [Full Text] [Related]
8. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study. Kalimuddin S; Chan YFZ; Phillips R; Ong SP; Archuleta S; Lye DC; Tan TT; Low JGH Trials; 2018 Jun; 19(1):305. PubMed ID: 29859132 [TBL] [Abstract][Full Text] [Related]
9. Development of multiple lung abscesses during daptomycin treatment for right-sided endocarditis caused by meticillin-resistant Staphylococcus aureus. Liu CY; Wang JL; Huang YT; Hsueh PR Int J Antimicrob Agents; 2008 Dec; 32(6):544-5. PubMed ID: 18789850 [No Abstract] [Full Text] [Related]
10. Daptomycin Use in United States Children's Hospitals. Larru B; Cowden CL; Zaoutis TE; Gerber JS J Pediatric Infect Dis Soc; 2015 Mar; 4(1):60-2. PubMed ID: 26407359 [TBL] [Abstract][Full Text] [Related]
11. [Severe daptomycin-induced myopathy]. Ferrera C; Vilacosta I; Vivas D; Olmos C Med Clin (Barc); 2012 Jun; 139(3):138-9. PubMed ID: 22285497 [No Abstract] [Full Text] [Related]
12. Daptomycin-associated myopathy induced by concomitant administration of mirabegron. Hagiya H; Kokado R; Okuno H; Tomono K Infection; 2019 Apr; 47(2):331-332. PubMed ID: 30430398 [No Abstract] [Full Text] [Related]
13. Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations. Bhavnani SM; Ambrose PG; Hammel JP; Rubino CM; Drusano GL Antimicrob Agents Chemother; 2015 Dec; 60(3):1600-7. PubMed ID: 26711755 [TBL] [Abstract][Full Text] [Related]
14. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial. Cheng MP; Lawandi A; Butler-Laporte G; Paquette K; Lee TC Trials; 2018 May; 19(1):297. PubMed ID: 29843781 [TBL] [Abstract][Full Text] [Related]
15. Treatment of staphylococcal infections with cyclic lipopeptides. Eisenstein BI Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():10-6. PubMed ID: 18226085 [TBL] [Abstract][Full Text] [Related]
16. Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia. Arrieta AC; Bradley JS; Popejoy MW; Bensaci M; Grandhi A; Bokesch P; Glasser C; Du L; Patino H; Kartsonis NA Pediatr Infect Dis J; 2018 Sep; 37(9):893-900. PubMed ID: 29406465 [TBL] [Abstract][Full Text] [Related]
17. Decreasing the probability of creatine phosphokinase elevations: clinical considerations for daptomycin dosing in obese patients. Donovan BJ; Mohr JF; Knapp AG; Eisenstein BI Clin Infect Dis; 2010 Oct; 51(8):989; author reply 989-90. PubMed ID: 20858080 [No Abstract] [Full Text] [Related]